vs

Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and Rumble Inc. (RUM). Click either name above to swap in a different company.

Rumble Inc. is the larger business by last-quarter revenue ($27.1M vs $18.6M, roughly 1.5× ENANTA PHARMACEUTICALS INC). ENANTA PHARMACEUTICALS INC runs the higher net margin — -64.1% vs -120.8%, a 56.6% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -10.5%). ENANTA PHARMACEUTICALS INC produced more free cash flow last quarter ($-11.8M vs $-31.7M). Over the past eight quarters, Rumble Inc.'s revenue compounded faster (15.2% CAGR vs 4.5%).

Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.

Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".

ENTA vs RUM — Head-to-Head

Bigger by revenue
RUM
RUM
1.5× larger
RUM
$27.1M
$18.6M
ENTA
Growing faster (revenue YoY)
ENTA
ENTA
+20.2% gap
ENTA
9.8%
-10.5%
RUM
Higher net margin
ENTA
ENTA
56.6% more per $
ENTA
-64.1%
-120.8%
RUM
More free cash flow
ENTA
ENTA
$19.9M more FCF
ENTA
$-11.8M
$-31.7M
RUM
Faster 2-yr revenue CAGR
RUM
RUM
Annualised
RUM
15.2%
4.5%
ENTA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ENTA
ENTA
RUM
RUM
Revenue
$18.6M
$27.1M
Net Profit
$-11.9M
$-32.7M
Gross Margin
5.5%
Operating Margin
-60.5%
-131.1%
Net Margin
-64.1%
-120.8%
Revenue YoY
9.8%
-10.5%
Net Profit YoY
46.4%
86.2%
EPS (diluted)
$-0.42
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENTA
ENTA
RUM
RUM
Q4 25
$18.6M
$27.1M
Q3 25
$15.1M
$24.8M
Q2 25
$18.3M
Q1 25
$14.9M
$23.7M
Q4 24
$17.0M
$30.2M
Q3 24
$14.6M
$25.1M
Q2 24
$18.0M
$22.5M
Q1 24
$17.1M
$17.7M
Net Profit
ENTA
ENTA
RUM
RUM
Q4 25
$-11.9M
$-32.7M
Q3 25
$-18.7M
$-16.3M
Q2 25
$-18.3M
Q1 25
$-22.6M
$-2.7M
Q4 24
$-22.3M
$-236.8M
Q3 24
$-28.8M
$-31.5M
Q2 24
$-22.7M
$-26.8M
Q1 24
$-31.2M
$-43.3M
Gross Margin
ENTA
ENTA
RUM
RUM
Q4 25
5.5%
Q3 25
-1.8%
Q2 25
Q1 25
-26.7%
Q4 24
-14.2%
Q3 24
-45.4%
Q2 24
-58.8%
Q1 24
-79.5%
Operating Margin
ENTA
ENTA
RUM
RUM
Q4 25
-60.5%
-131.1%
Q3 25
-121.6%
-113.6%
Q2 25
-103.2%
Q1 25
-164.3%
-153.5%
Q4 24
-138.8%
-80.1%
Q3 24
-204.4%
-131.0%
Q2 24
-134.6%
-172.7%
Q1 24
-192.1%
-197.4%
Net Margin
ENTA
ENTA
RUM
RUM
Q4 25
-64.1%
-120.8%
Q3 25
-123.6%
-65.7%
Q2 25
-99.7%
Q1 25
-151.7%
-11.2%
Q4 24
-131.4%
-783.2%
Q3 24
-197.3%
-125.9%
Q2 24
-126.1%
-119.2%
Q1 24
-182.7%
-244.1%
EPS (diluted)
ENTA
ENTA
RUM
RUM
Q4 25
$-0.42
$-0.13
Q3 25
$-0.88
$-0.06
Q2 25
$-0.85
Q1 25
$-1.06
$-0.01
Q4 24
$-1.05
$-1.17
Q3 24
$-1.36
$-0.15
Q2 24
$-1.07
$-0.13
Q1 24
$-1.47
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENTA
ENTA
RUM
RUM
Cash + ST InvestmentsLiquidity on hand
$37.4M
$237.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$126.6M
$274.8M
Total Assets
$329.5M
$336.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENTA
ENTA
RUM
RUM
Q4 25
$37.4M
$237.9M
Q3 25
$32.3M
$269.8M
Q2 25
$44.8M
Q1 25
$60.2M
$301.3M
Q4 24
$84.3M
$114.0M
Q3 24
$37.2M
$132.0M
Q2 24
$35.8M
$154.2M
Q1 24
$63.5M
$183.8M
Stockholders' Equity
ENTA
ENTA
RUM
RUM
Q4 25
$126.6M
$274.8M
Q3 25
$64.7M
$302.2M
Q2 25
$79.3M
Q1 25
$93.5M
$339.6M
Q4 24
$111.8M
$-63.1M
Q3 24
$128.8M
$166.1M
Q2 24
$148.9M
$192.7M
Q1 24
$166.1M
$210.7M
Total Assets
ENTA
ENTA
RUM
RUM
Q4 25
$329.5M
$336.8M
Q3 25
$280.7M
$367.2M
Q2 25
$301.0M
Q1 25
$323.0M
$391.1M
Q4 24
$348.6M
$195.3M
Q3 24
$376.7M
$217.2M
Q2 24
$398.8M
$243.2M
Q1 24
$413.6M
$263.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENTA
ENTA
RUM
RUM
Operating Cash FlowLast quarter
$-11.7M
$-29.4M
Free Cash FlowOCF − Capex
$-11.8M
$-31.7M
FCF MarginFCF / Revenue
-63.6%
-117.2%
Capex IntensityCapex / Revenue
0.8%
8.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-18.5M
$-70.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENTA
ENTA
RUM
RUM
Q4 25
$-11.7M
$-29.4M
Q3 25
$-6.5M
$-10.6M
Q2 25
$17.5M
Q1 25
$-13.5M
$-14.5M
Q4 24
$-16.8M
$-12.4M
Q3 24
$-10.4M
$-19.1M
Q2 24
$-14.8M
$-21.7M
Q1 24
$-28.6M
$-33.9M
Free Cash Flow
ENTA
ENTA
RUM
RUM
Q4 25
$-11.8M
$-31.7M
Q3 25
$-7.9M
$-12.0M
Q2 25
$17.4M
Q1 25
$-16.0M
$-14.6M
Q4 24
$-25.5M
$-12.4M
Q3 24
$-19.4M
$-19.9M
Q2 24
$-21.3M
$-23.1M
Q1 24
$-30.3M
$-34.3M
FCF Margin
ENTA
ENTA
RUM
RUM
Q4 25
-63.6%
-117.2%
Q3 25
-52.5%
-48.6%
Q2 25
94.7%
Q1 25
-107.4%
-61.7%
Q4 24
-150.6%
-40.9%
Q3 24
-132.5%
-79.5%
Q2 24
-118.6%
-102.8%
Q1 24
-177.5%
-193.3%
Capex Intensity
ENTA
ENTA
RUM
RUM
Q4 25
0.8%
8.5%
Q3 25
9.6%
5.7%
Q2 25
0.8%
Q1 25
17.0%
0.6%
Q4 24
51.6%
0.1%
Q3 24
61.3%
3.4%
Q2 24
36.4%
6.1%
Q1 24
9.8%
2.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENTA
ENTA

Segment breakdown not available.

RUM
RUM

Audience Monetization$23.8M88%
Other Initiatives$3.3M12%

Related Comparisons